Komori
Fuji Pharma (4554) · RiskMaterialised

Impairment of Idle Equipment Following the End of OLIC Made-to-Order Production

First written in FY2021. 1 of 1 entries say "Materialised", first in FY2021. Latest entry: FY2021.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Impairment Losses on Idle Fixed AssetsA theme 34 companies write about · 34 as a headwind · 0 as a tailwind

Fuji Pharma moved to the "Worse" side of this theme in 2021, 1 year after the typical company in this theme (2020).

The whole theme swung hardest in 2019: 6 of 13 companies on the "Worse" side.

12 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 34 companies compared. The sentences above are computed from all 34.
Full recordFilings, disclosures and news, newest first
  1. FY2021MaterialisedAnnual report

    「The company determined that profitability had declined because contract manufacturing had ended and the equipment could not be used for other purposes, and recorded the entire carrying amount as an impairment loss.」

    Newly states that the carrying amount of idle equipment of ¥11 million was recorded as an impairment loss because OLIC contract manufacturing ended and the equipment could not be repurposed.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impairment of Idle Equipment Following the End of OLIC Made-to-Order Production | Fuji Pharma Co.,Ltd. (4554) | Komori